sur Ottobock SE & Co. KGaA
Ottobock Sees Strong Growth in Revenue and Profitability in 9M 2025
Ottobock SE & Co. KGaA, a leader in the MedTech sector, reports significant financial growth for the first nine months of 2025. Core revenue increased by 13.6% to EUR 1,157.7 million compared to the same period in 2024. The underlying core EBITDA rose by 29.4% to EUR 281.1 million, enhancing the EBITDA margin by 3.0 percentage points to 24.3%.
The company attributes this growth to successful product launches, strategic acquisitions, and positive reimbursement trends. In addition, the EMEA, Americas, and APAC segments posted substantial revenue increases due to high demand for new technologies like the Genium X4 and C-Brace products.
Looking forward, Ottobock confirms a positive outlook for 2025, projecting core business growth between 10.0% and 13.0%, supported by anticipated organic revenue growth in the upper range of 9.0% to 12.0%.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Ottobock SE & Co. KGaA